SEKISUI Diagnostics provides diagnostic products and services, including clinical chemistry reagents, point-of-care testing, and biopharma services. The company is involved in the development, manufacturing, and supply of various diagnostic solutions.

SEKISUI Diagnostics

Biotechnology Research

BioProduction by SEKISUI

SEKISUI Diagnostics | 13,843 followers on LinkedIn. Headquartered in Burlington, MA, for 40 years SEKISUI Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. We continue to invest in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems, and have a leading position as a provider of rapid tests in the US and high throughput coagulation systems in Japan.
Our workforce spans six sites located in four countries.

Embedded Software Consultant @ SEKISUI Diagnostics | Yocto Project, Defect Management

Jean-Pierre Sainfeld

Sr. Manager, HR Business Partner at Sekisui Diagnostics, LLC

Jenny Clark, SPHR, CCP

Karen Choquet

Eyvonne Therrien

Artificial intelligence is here. It's a tool that can provide tremendous opportunities and challenging obstacles for the care continuum. The major question facing healthcare organizations is how to harness this technology ethically and efficiently. Read More: https://hubs.ly/Q02Yf_6h0 #Healthcare #medicine #pointof care

On this World Diabetes Day, we emphasize the importance of holistic health for those affected by diabetes. Let's unite in raising awareness, supporting those impacted, and advocating for accessible, quality care for all. #WorldDiabetesDay #HealthAndWellbeing

Medica 2024 is in full swing! Come see us in Hall 1/D59. #MEDICA2024

The excitement continues on the second day of the JIB conference in Paris. Thank you to everyone who stopped by the SEKISUI Diagnostics stand to explore the OSOM® product range. #JIB2024 #InnovationInHealthcare #OSOM

November is Pancreatic Cancer Awareness Month At SEKISUI Diagnostics, we're committed to empowering healthcare professionals with the knowledge and tools they need to support early detection and improve patient outcomes. Together, through shared knowledge and continuous advancement, we can make meaningful strides against pancreatic cancer. #PancreaticCancerAwareness

We are thrilled to announce our participation in the JIB conference in Paris on November 7th and 8th. Visit us at stand 7 to discover more about our OSOM® product range. #JIB2024 #Innovation #OSOM

Medica 2024 is almost here! Come visit us in Dusseldorf, Germany as our Global Commercial Team will be there to discuss our products and services and how we can enhance your diagnostic offering. We would love to see you! Hall 1/D59 https://lnkd.in/djF85sP

Two weeks after InnoTrans our SEKISUI team shares insights of our presence, their on-site experiences and the importance of being at the biggest railway fair in the world, where the SEKISUI Team was exhibiting the FFU Railway Synthetic Sleepers. 🚆 Find out more about our lightweight and durable sleepers with our experts Clemens Bretschneider , Thorsten Delfs and Patrick Childs . #oneSEKISUI #SEKISUI #InnoTrans #Railway #FFU #FFUSleepers #sleepers #exhibition SEKISUI FFU Railway Technology

SEKISUI EUROPE

We are thrilled to be exhibiting at MEDEXPO Africa 2024 in Tanzania! The MEDEXPO Africa exhibition is the largest trade event for the healthcare and medical sector in the region. Join us at stand B185A to learn more about our point-of-care products. #Medexpo #AfricaHealthcare #OSOM

Microsoft Exchange Online

Microsoft Azure DNS

Register.com DNS

Senior Director, R&D and Regulatory, IVD BU

Allen Chun

Quality

Angela Tapu

Marketing and Product

David Morris, PhD (he/him/his)

Associate Director, R&D

Dhana Nair-Schaef

Associate Director Product Services- Applications

Donna Lee

Associate Director, Human Resources

Helene Friedlander

Global Director of Product Marketing

Jeff Swain

Associate Director, Business Development

Jim Alferman

Director of Corporate Alliances and Channel Management

Jonathan Overbey

Director Global Services

Julie Fadel

Jenny Clark

Principal Human Resources Business Partner

New England Companies With More Than $50M in Revenue

Greater Boston Area Companies With More Than 10 Employees (Top 10K)

Greater Boston Area Manufacturing Companies

New England Companies With More Than 10 Employees (Top 10K)

Sekisui Diagnostics, a leading developer and manufacturer of enzymes for the global healthcare market. Their quality, expertise, and customer focus are the reasons why global organisations choose Sekisui Diagnostics as their partner of choice.

They listen, understand, develop, and consistently deliver your exact requirements on time and to your total satisfaction. We are passionate about what we do, want to make a difference, and set ourselves very high standards.

Whatever your interest - whether you are looking to partner with a world leading manufacturer, need enzymes to develop a new product, or require support to commercialise a new invention - we would love to hear from you.

Lexington

Massachusetts

United States

North America

Sekisui Diagnostics

SEKISUI Diagnostics Receives Emergency Use Authorization for the OSOM® Flu SARS-CoV-2 Combo Test

SEKISUI's combo flu and Covid-19 test obtains EUA

Diagnostic Enzymes Market was valued at US$4.646 billion in 2022, witnessing significant growth

Point of Care Diagnostics Market is Booming Worldwide with a CAGR of 10.2%

SEKISUI signs Covid-19 test distribution deal with Aptitude in US

SEKISUI Diagnostics announces the Launch of the OSOM® COVID-19 Antigen Home Test

Mesa Biotech Provides Corporate Update

Boom island: Little Prince Edward Island enjoying a buoyant economy

A broad line of reagents including cardiovascular, diabetes, renal, liver, therapeutic drug, and specialty assays, used on various clinical chemistry analyzers.

Rapid tests and diagnostic readers for various conditions, including COVID-19, influenza, and pregnancy, providing quick and accurate results.

Enzymes used in clinical chemistry applications, such as cholesterol oxidase and glucose dehydrogenase, for testing diabetes, lipid metabolism, and other functions.

Enzymes for PCR applications, including DNA polymerases, used in infectious disease and oncology fields.

Detection and labeling materials for immunoassay applications, including streptavidin and alkaline phosphatase, used in immunology and molecular diagnostics.

Enzymes for inactivation of Beta-Lactam antibiotics, ensuring contamination-free production environments in antibiotic manufacturing.

news impact assignment basic	general
public peers	general	Nov 15, 2024 3:06 AM	3edad6da
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 15, 2024 3:06 AM	07d9001a
crunchbase trigger	general	Nov 15, 2024 3:06 AM	36c59140
crunchbase profile	general	Nov 15, 2024 5:17 PM	493f40a0
li profile	general	Nov 15, 2024 3:06 AM	c2853780
translate crunchbase fundingrounds	general	Nov 15, 2024 5:40 PM	264abe5f
peers	general	Nov 15, 2024 3:06 AM	4529d97b
news basic	general	Nov 15, 2024 3:06 AM	1cf07190
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

SEKI

COM:SEKISUIDIAGNOSTICS

SEKISUI Diagnostics